87
Participants
Start Date
October 1, 2020
Primary Completion Date
July 28, 2023
Study Completion Date
July 11, 2024
ZW25 (Zanidatamab)
Administered intravenously
Radiomed (Clinica Alemana de Temuco), Temuco
Fondazione del Piemonte per l'Oncologia (IRCCS), Candiolo
Memorial Sloan Kettering Cancer Center, New York
Hopitaux de La Timone, Marseille
Seoul National University Bundang Hospital, Seongnam
Hospital Universitario Reina Sofia, Córdoba
Istituto Clinico Humanitas, Milan
Istituto Nazionale Dei Tumori, Milan
University of Maryland Greenebaum Cancer Center, Baltimore
Oncologie médicale Hopital Jean Minjoz, Besançon
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Universitario Doce de Octubre, Madrid
Institut de Cancerologie et d'Hematologie Hopital Morvan - CHRU de Brest, Brest
Winship Cancer Institute, Emory University, Atlanta
Advent Health Cancer Institute, Orlando
Istituto Oncologico Veneto - I.R.C.C.S., Padua
Pusan National University Hospital, Pusan
Hospital Miguel Servet, Zaragoza
Gyeongsang National University Hospital, Jinju
Washington University School of Medicine, St Louis
University of Texas Southwestern Medical Center - Hospital, Dallas
University of Texas MD Anderson Cancer Center, Houston
Banner MD Anderson Cancer Center, Gilbert
Département Oncologie Gastro-entérologie CHRU de Poitiers La Miletrie, Poitiers
University of California Los Angeles, Santa Monica
The Oncology Institute of Hope and Innovation, Whittier
City of Hope National Medical Center, Duarte
Département De Médecine, Villejuif
University of Arizona Cancer Center, Tucson
Oregon Health and Science University, Portland
Seattle Cancer Care Alliance, Seattle
Beijing Cancer Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Jilin Cancer Hospital, Changchun
Affiliated Tumor Hospital of Harbin Medical University, Harbin
Affiliated Zhongshan Hospital of Fudan University, Shanghai
The Third Affiliated Hospital of the Chinese PLA, Shanghai
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing
Anhui Provincial Hospital, Hefei
Shandong Provincial Third Hospital, Shandong
Weifang People's Hospital, Weifang
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital of Zhejiang University, Hangzhou
Zhejiang Provincial People's Hospital, Hangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Huzhou Central Hospital, Huzhou
Jinhua Central Hospital, Jinhua
Hunan Cancer Hospital, Changsha
Hubei Cancer Hospital, Wuhan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
West China Hospital, Chengdu
The First Hospital Of Lanzhou University, Lanzhou
Centro de Cáncer Nuestra Señora de la Esperanza, Santiago
Princess Margaret Hospital, Toronto
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center Hospital, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Hospital Universitario Vall d'Hebron, Barcelona
Universitario Germans Trias i Pujol, Barcelona
Corporacio Sanitaria Parc Tauli, Sabadell
University College London Hospitals (UCLH), London
Royal Free London NHS Foundation Trust, London
Imperial College Healthcare NHS Trust, London
Lead Sponsor
Collaborators (3)
BeiGene
INDUSTRY
Jazz Pharmaceuticals Ireland Limited
INDUSTRY
BeOne Medicines LTD
UNKNOWN
Jazz Pharmaceuticals
INDUSTRY